Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04095273
Title Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the ATR Inhibitor BAY1895344 in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DEU

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94304 United States Details
Yale Cancer Center New Haven Connecticut 06519 United States Details
Johns Hopkins Hospital/Health System Baltimore Maryland 21287 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115-6084 United States Details
Weill Cornell Medical College New York New York 10021 United States Details
Levine Cancer Institute Charlotte North Carolina 28204-2990 United States Details
Ohio State University Columbus Ohio 43210 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030-4000 United States Details
Universitätsklinikum Heidelberg Heidelberg Baden-Württemberg 69120 Germany Details
Eberhard-Karls-Universität Tübingen Tübingen Baden-Württemberg 72076 Germany Details
Fundacion Jimenez Diaz (Clinica de la Concepcion) Madrid 28040 Spain Details
Hospital Madrid Norte Sanchinarro Madrid 28050 Spain Details
Kantonsspital St. Gallen St. Gallen Sankt Gallen 9007 Switzerland Details
Ospedale Regionale di Bellinzona e Valli Bellinzona Ticino 6500 Switzerland Details
Royal Marsden NHS Trust (Surrey) Sutton Surrey SM2 5PT United Kingdom Details
Freeman Hospital Newcastle Tyne And Wear NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field